The Latin America, Middle East and Africa Hydrogel-based Drug Delivery System Market is expected to witness market growth of 9.1% CAGR during the forecast period (2021-2027).
Natural & synthetic hydrogels are integrated to formulate hybrid hydrogels. The phenomenon of hybrid polymerization is utilized in the manufacturing of an improved version known as SMART hydrogel. These SMART hydrogels are stimuli-responsive and distinct from traditional hydrogels since the drug release is reliant on physical or chemical stimuli. The physical stimuli consist of pressure, magnetic, temperature, and electric field allowing targeted drug delivery utilizing hydrogels. For example, a PH sensitive was made by integrating polyacrylic acid along with natural polymers.
The presence of emerging nations like Nigeria, where the healthcare structure is not very strong that might slow down the products’ demand in these nations. In addition, the limited spending of the people in this region has hindered the demand for the hydrogel-based drug delivery system in this region. However, countries like South Africa are increasingly spending on the healthcare system and the governments of such countries are increasing their budget on building advanced healthcare systems.
Moreover, the adoption rate of the advanced or improved technologies in this region is comparatively lower than in other regions, which is expected to further limit the demand for the hydrogel-based drug delivery system market in LAMEA region.
The Ocular market dominated the South Africa Hydrogel-based Drug Delivery System Market by Delivery Route in 2020, thereby, achieving a market value of $39.4 Million by 2027. The Subcutaneous market is showcasing a CAGR of 9.7% during (2021 - 2027). Additionally, The Oral Cavity market is expected to witness highest CAGR of 10.2% during (2021 - 2027).
Based on Polymer Origin, the market is segmented into Synthetic, Natural and Hybrid. Based on Delivery Route, the market is segmented into Ocular, Subcutaneous, Oral Cavity, Topical and Other Delivery Routes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Inc., Medtronic PLC, Galderma S.A., Endo International PLC, Ferring Holdings SA, Akorn Operating Company LLC, Tolmar Pharmaceuticals, Inc., Blairex Laboratories, Inc., and Ocular Therapeutix, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Polymer Origin
- Synthetic
- Natural
- Hybrid
By Delivery Route
- Ocular
- Subcutaneous
- Oral Cavity
- Topical
- Other Delivery Routes
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- Bausch Health Companies, Inc.
- Medtronic PLC
- Galderma S.A.
- Endo International PLC
- Ferring Holdings SA
- Akorn Operating Company LLC
- Tolmar Pharmaceuticals, Inc.
- Blairex Laboratories, Inc.
- Ocular Therapeutix, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Johnson & Johnson
- Bausch Health Companies, Inc.
- Medtronic PLC
- Galderma S.A.
- Endo International PLC
- Ferring Holdings SA
- Akorn Operating Company LLC
- Tolmar Pharmaceuticals, Inc.
- Blairex Laboratories, Inc.
- Ocular Therapeutix, Inc.
Methodology
LOADING...
